英国脂肪肉瘤患者的流行病学和生存结果:使用真实世界数据的观察队列研究
Jessie O Oyinlola1, Mounia Beloueche-Babari2, Monika Frysz2
1Clinical Practice Research Datalink (CPRD), Safety and Surveillance Group, Medicines and Healthcare Products Regulatory Agency, London, UK.
Rare tumors
|July 30, 2025
概括
这项针对脂肪肉瘤患者的研究发现,五年生存率为77%. 了解真实世界的患者数据,治疗模式和结果对于管理这种罕见的癌症至关重要.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 医疗信息学 医疗信息学
背景情况:
- 脂肉瘤是一种罕见且异质的癌症.
- 了解真实世界的患者特征和治疗模式对于改善临床管理至关重要.
研究的目的:
- 评估脂瘤瘤患者的人口统计和临床特征.
- 在现实环境中分析治疗模式和生存结果.
- 为了为脂质瘤的临床管理策略提供信息.
主要方法:
- 使用临床实践研究数据链接数据 (1998-2018) 的回顾性队列研究.
- 包括成人患者 (≥18岁) 首次被诊断患有脂肪肉瘤.
- 对人口统计,瘤特征,治疗数据和生存率的分析.
主要成果:
- 包括1,315名脂瘤瘤患者;其中46%的患者已记录治疗.
- 手术是最常见的治疗方法 (34%),其次是放射治疗 (8%) 和化疗 (2.4%).
- 诊断后整体5年生存概率为77%.
结论:
- 现实世界的数据提供了对脂质瘤患者特征,治疗和生存的宝贵见解.
- 这些发现可以指导这种罕见的癌症的临床管理.
- 改善现实世界的数据收集和标准化是必要的.
相关概念视频
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Actuarial Approach
137
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
137
Kaplan-Meier Approach
270
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
270
Comparing the Survival Analysis of Two or More Groups
289
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
289
Introduction To Survival Analysis
400
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
400
Assumptions of Survival Analysis
198
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
198


